EGF Theramed Health Corp. (TMED.CN)
EGF Theramed Health Corp. operates in the Medical - Healthcare Information Services industry of the Healthcare sector, headquartered in Vancouver, BC, CA. The stock last traded at $0.07, down 12.50% on the session, giving a market capitalisation of $813,167. Its beta of 0.28 implies it has historically moved less than the broad market.
EGF Theramed Health Corp. focuses on providing psychedelic-based therapies to address various mental health challenges. The company's products are specifically utilized in the treatment of conditions such as intractable depression, anxiety disorders, post-traumatic stress disorder (PTSD), and general depression. Established in 2011, this firm operates from its main headquarters in Vancouver, Canada.
EGF Theramed Health Corp. is most often compared with the following Healthcare names: